Sage Rhino Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$203K Sell
4,375
-149
-3% -$6.9K 0.04% 243
2025
Q1
$276K Buy
4,524
+246
+6% +$15K 0.06% 177
2024
Q4
$242K Buy
4,278
+56
+1% +$3.17K 0.05% 198
2024
Q3
$218K Buy
+4,222
New +$218K 0.05% 230
2024
Q2
Sell
-3,884
Closed -$211K 253
2024
Q1
$211K Sell
3,884
-86
-2% -$4.66K 0.05% 204
2023
Q4
$204K Sell
3,970
-187
-4% -$9.6K 0.05% 202
2023
Q3
$241K Sell
4,157
-103
-2% -$5.98K 0.07% 176
2023
Q2
$272K Sell
4,260
-292
-6% -$18.7K 0.08% 171
2023
Q1
$315K Buy
4,552
+239
+6% +$16.6K 0.09% 154
2022
Q4
$310K Buy
4,313
+74
+2% +$5.32K 0.1% 154
2022
Q3
$301K Sell
4,239
-86
-2% -$6.11K 0.12% 128
2022
Q2
$333K Buy
4,325
+72
+2% +$5.54K 0.13% 134
2022
Q1
$311K Sell
4,253
-11
-0.3% -$804 0.09% 160
2021
Q4
$266K Sell
4,264
-3,682
-46% -$230K 0.07% 177
2021
Q3
$470K Buy
7,946
+10
+0.1% +$591 0.14% 112
2021
Q2
$530K Sell
7,936
-2,238
-22% -$149K 0.16% 104
2021
Q1
$642K Buy
10,174
+25
+0.2% +$1.58K 0.21% 85
2020
Q4
$630K Sell
10,149
-89
-0.9% -$5.53K 0.25% 75
2020
Q3
$617K Sell
10,238
-290
-3% -$17.5K 0.3% 66
2020
Q2
$619K Buy
10,528
+209
+2% +$12.3K 0.33% 64
2020
Q1
$575K Buy
10,319
+303
+3% +$16.9K 0.41% 51
2019
Q4
$653K Buy
10,016
+4,931
+97% +$321K 0.37% 60
2019
Q3
$258K Buy
5,085
+324
+7% +$16.4K 0.16% 113
2019
Q2
$216K Sell
4,761
-66
-1% -$2.99K 0.14% 119
2019
Q1
$230K Buy
+4,827
New +$230K 0.15% 110